Tower Research Capital (TRC)’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $52.2K | Buy |
2,416
+410
| +20% | +$7.57K | ﹤0.01% | 2707 |
|
|
2025
Q4 | $27.5K | Sell |
2,006
-1,012
| -34% | -$15.8K | ﹤0.01% | 2864 |
|
|
2025
Q3 | $53.4K | Buy |
3,018
+78
| +3% | +$1.23K | ﹤0.01% | 2479 |
|
|
2025
Q2 | $44.4K | Buy |
2,940
+2,156
| +275% | +$35.8K | ﹤0.01% | 3075 |
|
|
2025
Q1 | $12.6K | Sell |
784
-908
| -54% | -$16.9K | ﹤0.01% | 3435 |
|
|
2024
Q4 | $29.5K | Buy |
1,692
+838
| +98% | +$14.8K | ﹤0.01% | 2917 |
|
|
2024
Q3 | $15K | Sell |
854
-1,431
| -63% | -$24.4K | ﹤0.01% | 3430 |
|
|
2024
Q2 | $25.6K | Buy |
2,285
+1,673
| +273% | +$15.8K | ﹤0.01% | 3601 |
|
|
2024
Q1 | $5.33K | Sell |
612
-2,155
| -78% | -$19.8K | ﹤0.01% | 4556 |
|
|
2023
Q4 | $33.9K | Sell |
2,767
-7,991
| -74% | -$55.3K | ﹤0.01% | 3354 |
|
|
2023
Q3 | $43.4K | Buy |
10,758
+1,309
| +14% | +$8.13K | ﹤0.01% | 2672 |
|
|
2023
Q2 | $67.9K | Buy |
+9,449
| New | +$60.4K | ﹤0.01% | 2326 |
|
|
2023
Q1 | – | Sell |
-160
| Closed | – | – | 6183 |
|
|
2022
Q4 | $0 | Buy |
+160
| New | +$359 | ﹤0.01% | 6253 |
|
|
2022
Q3 | – | Sell |
-4,131
| Closed | -$6K | – | 6390 |
|
|
2022
Q2 | $6K | Buy |
4,131
+1,501
| +57% | +$3.77K | ﹤0.01% | 4942 |
|
|
2022
Q1 | $13K | Buy |
2,630
+1,551
| +144% | +$12.7K | ﹤0.01% | 3994 |
|
|
2021
Q4 | $16K | Buy |
1,079
+71
| +7% | +$1.41K | ﹤0.01% | 3927 |
|
|
2021
Q3 | $22K | Sell |
1,008
-646
| -39% | -$13.9K | ﹤0.01% | 3637 |
|
|
2021
Q2 | $27K | Sell |
1,654
-652
| -28% | -$12.4K | ﹤0.01% | 3606 |
|
|
2021
Q1 | $54K | Sell |
2,306
-2,208
| -49% | -$66K | ﹤0.01% | 3059 |
|
|
2020
Q4 | $108K | Sell |
4,514
-10,125
| -69% | -$161K | ﹤0.01% | 2276 |
|
|
2020
Q3 | $173K | Buy |
14,639
+11,949
| +444% | +$129K | ﹤0.01% | 2703 |
|
|
2020
Q2 | $28K | Buy |
2,690
+2,427
| +923% | +$21.9K | ﹤0.01% | 3489 |
|
|
2020
Q1 | $2K | Buy |
263
+63
| +32% | +$654 | ﹤0.01% | 2624 |
|
|
2019
Q4 | $3K | Buy |
200
+25
| +14% | +$356 | ﹤0.01% | 2946 |
|
|
2019
Q3 | $3K | Buy |
+175
| New | +$2.27K | ﹤0.01% | 3576 |
|
|
2019
Q2 | – | Sell |
-49
| Closed | -$1K | – | 4144 |
|
|
2019
Q1 | $1K | Sell |
49
-1,228
| -96% | -$19.3K | ﹤0.01% | 3602 |
|
|
2018
Q4 | $15K | Sell |
1,277
-1,535
| -55% | -$18.6K | ﹤0.01% | 2165 |
|
|
2018
Q3 | $39K | Buy |
+2,812
| New | +$40K | ﹤0.01% | 1920 |
|
|
2018
Q1 | – | Sell |
-8,030
| Closed | -$190K | – | 3706 |
|
|
2017
Q4 | $190K | Buy |
8,030
+2,169
| +37% | +$51.2K | 0.02% | 577 |
|
|
2017
Q3 | $109K | Buy |
+5,861
| New | +$133K | 0.01% | 1276 |
|
|
2016
Q4 | – | Sell |
-300
| Closed | -$2K | – | 4270 |
|
|
2016
Q3 | $2K | Sell |
300
-300
| -50% | -$1.53K | ﹤0.01% | 3120 |
|
|
2016
Q2 | $3K | Buy |
+600
| New | +$2.58K | ﹤0.01% | 3728 |
|
Other funds holding PLSE
VCM
PCM
GAM
LP
Tower Research Capital (TRC)'s PLSE Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its Pulse Biosciences (PLSE) stake by 20% in Q1 2026, buying an estimated $7.57K and bringing the position to 2,416 shares worth $52.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2707.
Tower Research Capital (TRC) first reported a position in PLSE in Q2 2016 and has held it in 32 quarters since. The position peaked at $190K in Q4 2017. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.
- Tower Research Capital (TRC) held 2,416 shares of Pulse Biosciences worth $52.2K as of Q1 2026.
- Tower Research Capital (TRC) bought 410 Pulse Biosciences shares in Q1 2026, an estimated $7.57K.
- Pulse Biosciences made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #2707 holding.
- Tower Research Capital (TRC) first reported a position in Pulse Biosciences in Q2 2016 and has held it in 32 quarters since.
- Tower Research Capital (TRC)'s Pulse Biosciences position peaked at $190K in Q4 2017.
- 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.